Time to Cardiovascular Death and First Major Adverse Cardiovascular Event (MACE)
cardiovascular death
EVENTS
Sacubitril/valsartan vs valsartan was associated with an unadjusted hazard ratio (HR) for cardiovascular death and major adverse cardiovascular events of 0.35 (95% CI, 0.17 to 0.74; 